Page last updated: 2024-11-12

dibromophakellstatin

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

dibromophakellstatin: from the Indian Ocean sponge, Phakellia mauritiana; structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID10500579
CHEMBL ID390234
SCHEMBL ID14442127
MeSH IDM0273625

Synonyms (6)

Synonym
dibromophakellstatin
(+/-)-dibromophakellstatin
CHEMBL390234
(-)-dibromophakellstatin
SCHEMBL14442127
(1r,5s)-7,8-dibromo-2,4,6,12-tetrazatetracyclo[10.3.0.01,5.06,10]pentadeca-7,9-diene-3,11-dione
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (32)

Assay IDTitleYearJournalArticle
AID402523Cytotoxicity against human OVCAR5 cells by SRB assay1997Journal of natural products, Feb, Volume: 60, Issue:2
Antineoplastic agents. 362. Isolation and X-ray crystal structure of dibromophakellstatin from the Indian ocean sponge Phakellia mauritiana.
AID671270Inhibition of chymotryptic-like of purified human 20S proteasome using Suc-LLVY-AMC as substrate after 30 mins by fluorescence assay2012Journal of natural products, May-25, Volume: 75, Issue:5
Palau'amine and related oroidin alkaloids dibromophakellin and dibromophakellstatin inhibit the human 20S proteasome.
AID292869Antiproliferative activity against human MEXF 394NL cells2007Bioorganic & medicinal chemistry letters, Jan-15, Volume: 17, Issue:2
Antitumor activity of the marine natural product dibromophakellstatin in vitro.
AID671273Inhibition of chymotryptic-like of purified human 20S immunoproteasome2012Journal of natural products, May-25, Volume: 75, Issue:5
Palau'amine and related oroidin alkaloids dibromophakellin and dibromophakellstatin inhibit the human 20S proteasome.
AID292858Antiproliferative activity against human CNXF 498NL cells2007Bioorganic & medicinal chemistry letters, Jan-15, Volume: 17, Issue:2
Antitumor activity of the marine natural product dibromophakellstatin in vitro.
AID402512Cytotoxicity against human K562 cells by SRB assay1997Journal of natural products, Feb, Volume: 60, Issue:2
Antineoplastic agents. 362. Isolation and X-ray crystal structure of dibromophakellstatin from the Indian ocean sponge Phakellia mauritiana.
AID402526Cytotoxicity against human PC3 cells by SRB assay1997Journal of natural products, Feb, Volume: 60, Issue:2
Antineoplastic agents. 362. Isolation and X-ray crystal structure of dibromophakellstatin from the Indian ocean sponge Phakellia mauritiana.
AID402521Cytotoxicity against human SNB75 cells by SRB assay1997Journal of natural products, Feb, Volume: 60, Issue:2
Antineoplastic agents. 362. Isolation and X-ray crystal structure of dibromophakellstatin from the Indian ocean sponge Phakellia mauritiana.
AID402508Cytotoxicity against human A498 cells by SRB assay1997Journal of natural products, Feb, Volume: 60, Issue:2
Antineoplastic agents. 362. Isolation and X-ray crystal structure of dibromophakellstatin from the Indian ocean sponge Phakellia mauritiana.
AID402518Cytotoxicity against human HCT116 cells by SRB assay1997Journal of natural products, Feb, Volume: 60, Issue:2
Antineoplastic agents. 362. Isolation and X-ray crystal structure of dibromophakellstatin from the Indian ocean sponge Phakellia mauritiana.
AID402506Cytotoxicity against human OVCAR-3 cells by SRB assay1997Journal of natural products, Feb, Volume: 60, Issue:2
Antineoplastic agents. 362. Isolation and X-ray crystal structure of dibromophakellstatin from the Indian ocean sponge Phakellia mauritiana.
AID402511Cytotoxicity against human SK-MEL-5 cells by SRB assay1997Journal of natural products, Feb, Volume: 60, Issue:2
Antineoplastic agents. 362. Isolation and X-ray crystal structure of dibromophakellstatin from the Indian ocean sponge Phakellia mauritiana.
AID402515Cytotoxicity against human NCI-H226 cells by SRB assay1997Journal of natural products, Feb, Volume: 60, Issue:2
Antineoplastic agents. 362. Isolation and X-ray crystal structure of dibromophakellstatin from the Indian ocean sponge Phakellia mauritiana.
AID292854Antiproliferative activity against human SF268 cells2007Bioorganic & medicinal chemistry letters, Jan-15, Volume: 17, Issue:2
Antitumor activity of the marine natural product dibromophakellstatin in vitro.
AID402525Cytotoxicity against human 786-0 cells by SRB assay1997Journal of natural products, Feb, Volume: 60, Issue:2
Antineoplastic agents. 362. Isolation and X-ray crystal structure of dibromophakellstatin from the Indian ocean sponge Phakellia mauritiana.
AID402513Cytotoxicity against human A549 cells by SRB assay1997Journal of natural products, Feb, Volume: 60, Issue:2
Antineoplastic agents. 362. Isolation and X-ray crystal structure of dibromophakellstatin from the Indian ocean sponge Phakellia mauritiana.
AID402524Cytotoxicity against human OVCAR8 cells by SRB assay1997Journal of natural products, Feb, Volume: 60, Issue:2
Antineoplastic agents. 362. Isolation and X-ray crystal structure of dibromophakellstatin from the Indian ocean sponge Phakellia mauritiana.
AID402507Cytotoxicity against human SF295 cells by SRB assay1997Journal of natural products, Feb, Volume: 60, Issue:2
Antineoplastic agents. 362. Isolation and X-ray crystal structure of dibromophakellstatin from the Indian ocean sponge Phakellia mauritiana.
AID402529Cytotoxicity against human Hs 578T cells by SRB assay1997Journal of natural products, Feb, Volume: 60, Issue:2
Antineoplastic agents. 362. Isolation and X-ray crystal structure of dibromophakellstatin from the Indian ocean sponge Phakellia mauritiana.
AID402520Cytotoxicity against human SF539 cells by SRB assay1997Journal of natural products, Feb, Volume: 60, Issue:2
Antineoplastic agents. 362. Isolation and X-ray crystal structure of dibromophakellstatin from the Indian ocean sponge Phakellia mauritiana.
AID292874Antiproliferative activity against human OVXF 899L cells2007Bioorganic & medicinal chemistry letters, Jan-15, Volume: 17, Issue:2
Antitumor activity of the marine natural product dibromophakellstatin in vitro.
AID402509Cytotoxicity against human H460 cells by SRB assay1997Journal of natural products, Feb, Volume: 60, Issue:2
Antineoplastic agents. 362. Isolation and X-ray crystal structure of dibromophakellstatin from the Indian ocean sponge Phakellia mauritiana.
AID402516Cytotoxicity against human NCI-H522 cells by SRB assay1997Journal of natural products, Feb, Volume: 60, Issue:2
Antineoplastic agents. 362. Isolation and X-ray crystal structure of dibromophakellstatin from the Indian ocean sponge Phakellia mauritiana.
AID292863Antiproliferative activity against human LXF 529L cells2007Bioorganic & medicinal chemistry letters, Jan-15, Volume: 17, Issue:2
Antitumor activity of the marine natural product dibromophakellstatin in vitro.
AID402510Cytotoxicity against human KM20L2 cells by SRB assay1997Journal of natural products, Feb, Volume: 60, Issue:2
Antineoplastic agents. 362. Isolation and X-ray crystal structure of dibromophakellstatin from the Indian ocean sponge Phakellia mauritiana.
AID671271Inhibition of caspase-like of purified human 20S proteasome using Z-LLE-AMC as substrate after 30 mins by fluorescence assay2012Journal of natural products, May-25, Volume: 75, Issue:5
Palau'amine and related oroidin alkaloids dibromophakellin and dibromophakellstatin inhibit the human 20S proteasome.
AID402522Cytotoxicity against human U251 cells by SRB assay1997Journal of natural products, Feb, Volume: 60, Issue:2
Antineoplastic agents. 362. Isolation and X-ray crystal structure of dibromophakellstatin from the Indian ocean sponge Phakellia mauritiana.
AID402517Cytotoxicity against human COLO205 cells by SRB assay1997Journal of natural products, Feb, Volume: 60, Issue:2
Antineoplastic agents. 362. Isolation and X-ray crystal structure of dibromophakellstatin from the Indian ocean sponge Phakellia mauritiana.
AID671272Inhibition of tryptic-like of purified human 20S proteasome using Boc-LRR-AMC as substrate after 30 mins by fluorescence assay2012Journal of natural products, May-25, Volume: 75, Issue:5
Palau'amine and related oroidin alkaloids dibromophakellin and dibromophakellstatin inhibit the human 20S proteasome.
AID402514Cytotoxicity against human HOP92 cells by SRB assay1997Journal of natural products, Feb, Volume: 60, Issue:2
Antineoplastic agents. 362. Isolation and X-ray crystal structure of dibromophakellstatin from the Indian ocean sponge Phakellia mauritiana.
AID402528Cytotoxicity against human MDA-MB-231 cells by SRB assay1997Journal of natural products, Feb, Volume: 60, Issue:2
Antineoplastic agents. 362. Isolation and X-ray crystal structure of dibromophakellstatin from the Indian ocean sponge Phakellia mauritiana.
AID402519Cytotoxicity against human HT-29 cells by SRB assay1997Journal of natural products, Feb, Volume: 60, Issue:2
Antineoplastic agents. 362. Isolation and X-ray crystal structure of dibromophakellstatin from the Indian ocean sponge Phakellia mauritiana.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (12)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's1 (8.33)18.2507
2000's8 (66.67)29.6817
2010's3 (25.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.71

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.71 (24.57)
Research Supply Index2.56 (2.92)
Research Growth Index5.28 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.71)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other12 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]